Interpharm Announces June 30, 2003 Results COMMACK, N.Y., Sept. 30, 2003 (PRIMEZONE) -- Interpharm Holdings, Inc (AMEX:IPA) today announced its operating results for the six-month period ended June 30, 2003. Interpharm changed its fiscal...

Interpharm Announces Launch of Allopurinol, the Second of Four Generic Drugs to be Manufactured Under an Agreement with URL/Mutual COMMACK, N.Y., Sept. 16, 2003 (PRIMEZONE) -- Interpharm Holdings, Inc. (AMEX:IPA) today announced that Interpharm, Inc., its wholly-owned subsidiary, has begun manufacturing Allopurinol Tablets for...

Interpharm Announces Launch of Contract Manufacturing Relationship with URL/Mutual COMMACK, N.Y., July 17, 2003 (PRIMEZONE) -- Interpharm Holdings, Inc. (AMEX:IPA) today announced that Interpharm, Inc., its wholly owned subsidiary, has begun manufacturing Atenolol Tablets for...

Interpharm Announces March 31, 2003 Quarterly Results COMMACK, N.Y., July 15, 2003 (PRIMEZONE) -- Interpharm Holdings, Inc. (AMEX:IPA) today announced the March 31, 2003 quarterly results for Interpharm, Inc, its wholly owned subsidiary. Interpharm,...